chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had headaches with first two doses of covid vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administration date 07Apr2021 08:40 (Lot number: ER8729) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COPD", start date: Mar2021 (unspecified if ongoing); "Covid-19", start date: Feb2021 (unspecified if ongoing), notes: She had Covid back in February prior to the vaccine. She got vertigo bad with covid virus when she had it back in Feb2021.; "She got vertigo bad with covid virus", start date: 2021 (unspecified if ongoing), notes: She got vertigo bad with covid virus when she had it back in Feb2021.; "had surgery in Apr2021", start date: Apr2021 (unspecified if ongoing), notes: had surgery in Apr2021 and was diagnosed in Mar2021. There were no concomitant medications.  The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "had headaches with first two doses of covid vaccine".  Additional Information: had surgery in Apr2021 and was diagnosed in Mar2021. She got vertigo bad with covid virus when she had it back in Feb2021 and was prescribed meclizine by her doctor. States she took meclizine after experiencing dizziness after the covid vaccine and it did not help a whole lot. The patient did not taken Prior Vaccinations (within 4 weeks). She had Covid back in February prior to the vaccine.. Meclizine dispensed in pharmacy bottle, oval white yellow tablet, sees on the pharmacy label.   Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101573064 similar report from same reporter;US-PFIZER INC-202101594319 2nd dose, BNT162B2
Pain in both shoulders restricting the range of motion and pain in right knee. These joints have osteoarthritis.
Patient received the shot and then came back to the pharmacy with the chief complaint of shortness of breath. She also described herself as feeling "off." We administered liquid diphenhydramine and after about 10 minutes the patient felt better and then left with no further complications.
This spontaneous report as received from a consumer refers to her daughter, a female patient of an unknown age. The patient's concurrent conditions and medical history were not reported. On an unknown date, the patient was vaccinated with fourth dose of GARDASIL or GARDASIL 9, both, unknown strength, route and dose. Concomitant medications were not reported. Consumer could not confirm if vaccine was GARDASIL or GARDASIL 9. It could not be confirmed if any adverse events occurred. There was no product quality complaint involved. Additional information has been requested.
got COVID; got COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (002191). The reporter is the parent.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "got COVID". The reporter stated both of her kids got their booster doses too and both of them got COVID-19. No one ended up needing to go to the hospital and no one ended up dying.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200165956 same reporter/vaccine/event, different patient.;US-PFIZER INC-202200165324 same reporter/vaccine, different patient and event.
no adverse effects were reported; improperly stored vaccine administered; This spontaneous report was received from a physician regarding a patient of an unknown age and gender. The patient's pertinent medical history, drug reaction and drug allergies were unknown. The patient's concomitant therapies included sterile diluent. On 10-APR-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot # R027993 and expiry date: 01-OCT-2020 (strength, dose, frequency, route not reported) for prophylaxis (product storage error). The vaccine underwent temperature excursion of 15 degree Fahrenheit (F) to 46 degree Fahrenheit (23F) for 3 hours. There was no previous temperature excursion involved. The call was due to digital data logger. No adverse effects reported (no adverse event). Product quality complaint was not involved.  This is one of several reports received from the same reporter.; Sender's Comments:  USA-009507513-1904USA010577: USA-009507513-1904USA011971: USA-009507513-1904USA011973: USA-009507513-1904USA011974: USA-009507513-1904USA011975: USA-009507513-1904USA011976: USA-009507513-1904USA011977: USA-009507513-1904USA011978: USA-009507513-1904USA011979:
keeps getting Covid; keeps getting Covid; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "keeps getting Covid". It was reported that patient has had bad impacts of and keeps getting Covid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt cried non-stop for 3 hrs & more; mom stated cried so hard that scalp broke out w/blood spots which lasted for several days a/disappearing; crying lasted several more hrs & stopped only when slept @  5-10 mins intervals; no fever;
On 11/21/2000 the patient had developed 50 lesions spread over his entire body and a low grade fever and was diagnosed with varicella. The patient recovered. No further information is expected.
Almost immediate pain in right hip area followed by rapid heart rate. Then experienced  sweating and overheating followed by chills and inability to get warm. Arms and hands started tingling and feeling numb and then it moved to my legs. Took Tylenol and tried to drink water and eat a little. Slept for several hours and then had a bad headache causing a little bit of nausea and still very sensitive in right hip area, took more Tylenol.
Fever and body aches for 48 hours.  Pain, swelling, heat and redness of deltoid area, gravitating distally to elbow, one week until resolution.
Received 2,5 ml of the Moderna Covid 19 vaccine as a booster dose; Person younger than 18 received a second booster dose of the Moderna Covid 19 vaccine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ACCIDENTAL OVERDOSE (Received 2,5 ml of the Moderna Covid 19 vaccine as a booster dose) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Person younger than 18 received a second booster dose of the Moderna Covid 19 vaccine) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AR45048, 700630007, 700632007 and 7006320005) for COVID-19 prophylaxis.     The patient had no allergies.  Concurrent medical conditions included Polycystic ovarian syndrome. Concomitant products included DROSPIRENONE, ETHINYLESTRADIOL BETADEX CLATHRATE (YAZ) for Birth control, METFORMIN for Polycystic ovarian syndrome.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2.5 milliliter. On 14-Jul-2022, the patient experienced ACCIDENTAL OVERDOSE (Received 2,5 ml of the Moderna Covid 19 vaccine as a booster dose) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Person younger than 18 received a second booster dose of the Moderna Covid 19 vaccine). At the time of the report, ACCIDENTAL OVERDOSE (Received 2,5 ml of the Moderna Covid 19 vaccine as a booster dose) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Person younger than 18 received a second booster dose of the Moderna Covid 19 vaccine) outcome was unknown.            Concomitant medications included antidepressants. It was reported that patient was part of the clinical trials of the Moderna Covid 19 vaccine and had received in the clinical trial the primary doses and the first booster dose. On 14-Jul-2022, patient received the second booster dose and had accidentally received 2.5ml No treatment medication was reported.   This case was linked to MOD-2022-609021, MOD-2022-609221 (Patient Link).
Joint pain, muscle pain, weakness, nausea started the previous night and persisted through the day. I took 2 Tylenol at 11:00 am and another dose of 2 pills at 6:00 pm. All symptoms were gone by the next morning.
FEW MINUTES POST VACCINE, PATIENT C/O THROAT TIGHTENING/SWELLING. DENIED SOB. BROUGHT TO OBS VIA WC, ASSISTED TO STRETCHER. VSS. PATIENT TOLERATING COLD WATER, AND DENIED WORSENING S/S; RESOLVED SPONTANEOUSLY AFTER A FEW MINUTES. ESCORTED TO EXIT WITH SIGNIFICANT OTHER WITH NO ISSUES AT 0830. INSTRUCTED TO SEEK FURTHER EVAL/TREATMENT FOR WORSENING/RECURRING S/S. 0820 BP 109/73 HR 78 RR 18 SATS 99% RA
p/vax pt exp chills, low grade fever, skin sensitivity, flu like sx & h/a; pt took advil for relief of sx; sx persisted; Dx=either ovarian or uterine CA
Information has been received from a nurse practitioner concerning a male patient who at the "beginning of December 2008" was vaccinated with ZOSTAVAX (Oka/Merck). 11-15 days after receiving ZOSTAVAX (Oka/Merck) "between December 2008 and January 2009" the patient developed a rash. The nurse noted that it was not a Varicella rash and was more like hives or urticaria and all over the whole body. The patient had sought unspecified medical attention. At the time of reporting the patient had recovered from adverse effect. Additional information has been requested.
On  day 7, got an itchy arm, have a bump there that is itchy at injection site and also arm is red, slightly hard and slightly swollen
Patient inadvertently received 4 doses of covid vaccines. She completed series of Pfizer in January and then received a complete series of Moderna (8/16/21 and 9/14/21). Patient reported only minor side effects (mild headache and upset stomach)
A report has been received from a Physician concerning a 9 year old, Female subject, who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on an unknown date. The patient was inadvertently given FLUMIST expired vaccine which started on 15-Dec-2014. The outcome of the event of EXPIRED FLUMIST ADMINISTRATION is unknown. The report was considered to be non-serious.
The day of vaccine 3-4 hours fever started, headache swollen lymph node in armpit area, I took1gram Tylenol and next day continued running fever never over 100 kept taking Tylenol, sore throat soreness in joints that I was not having problems with before hand and elbows and really bad neck pain. Fever 10-day low grade, lymph nodes stayed swollen, shortness of breath and cough, tested for COVID-19 and was negative, I attributed all the reactions to the vaccine Nausea and headache lasted 2-month pulsating at the base of skull, nausea with I tried to do anything active. Throat and lumps lasted 2 months and cough lasted 2 ½ months, fever broke after 10 day broke shortly and came back and lasted a while, I tested a second time for COVID-19 and was negative again.  Severe pressure in my ears, muffled sounds, doctors said possible encephalitic. Nov 8 some things started to go away. T-dap vaccine was done in 2013 and I wasn?t concerned about the protein in it.
2/22/ 2012 Started having pain in shoulder blade that went around to left breast.  Burning sensation and pain.  One 2/26/2021 red spot appeared on side of left breast. Feels and looks like Shingles.  I?ve had shingles in the past.
Site: Itching at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Autoimmune Disease (diagnosed by MD)-Mild, Additional Details: Patient states she had hives and swelling of upper lip. Did not require epinephrine a and onset was later in the evening after vaccince. states she has myasthenia gravis and believes reaction related to this, however, reported reaction and wanted pharmacy to be aware. No MD visit reported. Patient self medicated with benadryl. No reported difficulty breathing
Patient states she had a rash and red below the injection site, not at the injection site, but lower on her arm.
When I woke up the morning after the second shot my upper lip was inflated and numb.; When I woke up the morning after the second shot my upper lip was inflated and numb.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 30Mar2021 at 18.45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included hepatitis B. The patient had no known allergies. Concomitant medications included tenofovir disoproxil fumarate (VIREAD). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 19:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine in four weeks prior to COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had been tested for COVID-19. On 01Apr2021 at 07.00, the patient woke up in the morning after the second shot and experienced inflated and numb upper lips which got much better by noon. The patient did not receive any treatment for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 25Mar2021, the patient have undergone nasal swab and the result of the test was negative. The clinical outcome of the events inflated and numb upper lips was resolving at the time of this report.     No further information is expected. Information about lot/batch number cannot be obtained.
I feel fever after moderna booster; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (I feel fever after moderna booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I feel fever after moderna booster). At the time of the report, PYREXIA (I feel fever after moderna booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medications were not reported. The patient felt fever after booster and wanted to know if fever was side effect of booster.
Rec'd Tdap & felt discomfort like "punched in arm". Continued to feel discomfort throughout week & wkend. Cont'd pain and on 2/13 arm became weaker, decreased strength. Today looked in mirror about 1 inch below injection site & a bit toward the body is a 2 inch circle of redness & swelling. No drainage. Can lift arm with pain. Discomfort from collarbone to fingertips with numbness. (R) arm.
got covid-19 after 1st vaccine injection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got covid-19 after 1st vaccine injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got covid-19 after 1st vaccine injection). At the time of the report, COVID-19 (got covid-19 after 1st vaccine injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
itch; rash; Immediately on vaccination I had a heart flutter which lasted about less than second and went away and I felt OK.; stiffness; pain in left arm at the vaccination area/pain at the site of COVID-19 vaccination site; This is a spontaneous report from a contactable healthcare professional (patient). This 64-year-old female patient received dose 1 of BNT162B2 (lot number FH8020) via an unspecified route of administration on 15Oct2021 at 11:00 (at the age of 64-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included sinusitis/rhinitis. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications were none. It was unknown if the patient had any allergies. Immediately on vaccination (on 15Oct2021) the patient felt a heart flutter which lasted about less than second and went away and she felt okay. For the next 24 to 36 hours the patient had the usual expected stiffness and pain in left arm at the vaccination area. By 48 hours the stiffness and pain went away and there was no swelling or rash. Exactly two weeks (14 days) later on 29Oct2021, she began to have itch, rash and pain at the site of COVID-19 vaccination site on her left arm. Now (30Oct2021) was the second day and the condition seemed to be getting worse. The events were reported as serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of heart flutter and stiffness were recovered. The outcomes of itch, rash, and pain at the vaccination site were not recovered. It was also reported that since the vaccine the patient had not been tested for COVID-19.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Tingling lips and tongue; Swollen lips and tongue; Swollen lips and tongue; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Tingling lips and tongue), LIP SWELLING (Swollen lips and tongue) and SWOLLEN TONGUE (Swollen lips and tongue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PARAESTHESIA ORAL (Tingling lips and tongue), LIP SWELLING (Swollen lips and tongue) and SWOLLEN TONGUE (Swollen lips and tongue). At the time of the report, PARAESTHESIA ORAL (Tingling lips and tongue), LIP SWELLING (Swollen lips and tongue) and SWOLLEN TONGUE (Swollen lips and tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.
Woke up with regular headache, tinnitus, low grade headaches 40 days, after which intermittent headaches but tinnitus has not stopped for 6mo. Nothing given for tinnitus and only take OTC for the first regulars headache. Ongoing for both issue.
Diffuse vesicular rash w/crusted lesions in various phases, on erythematous bases mainly on back mainly on back of torso, some lesions present scattered on extremities and face/scalp, no evidence of secondary infection.
pt reports that she got her vaccine around 1pm and early evening started to get a headache, sore neck, nausea and feels just out of it.  She states today she still feel nauseous and out of it.
Soreness at site. Edgy, irritable, sore, muscle pain.  The biggest symptom different from flu vaccines was the muscle pain. 4-3-2015 I had routine blood work and muscle above site extremely sore. Never happened before so I assume it's still the effect of Prevnar 13 on muscle that I'm experiencing this swollen bicep from the blood draw.
Great amount of confusion; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Great amount of confusion) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (Great amount of confusion) (seriousness criterion hospitalization). At the time of the report, CONFUSIONAL STATE (Great amount of confusion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided. No treatment information mentioned.  Patient reported ending up in the medical hospital due to confusion state and that the same happened to his aunt.  Very limited information regarding this event has been provided at this time.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.